NEW YORK (GenomeWeb News) – Complete Genomics has hired Bill Homan as senior vice president and general counsel. His new role includes corporate governance, securities, legal compliance, litigation management, intellectual property management, and supporting executive compensation activities. Previously, he was senior vice president, general counsel, and secretary of Varian from 1999 until that firm was acquired by Agilent Technologies in 2010.
Thomas Hudson has been appointed to the Genome Quebec board of directors. Hudson is president and scientific director of the Ontario Institute for Cancer and a professor in the department of molecular genetics at the University of Toronto.
Additionally, he founded the McGill University and Genome Quebec Innovation Centre, which he managed from 2002 to 2006. He also served as assistant director of the Whitehead/MIT Center for Genome Research and was one of the founders of the International HapMap Consortium, the Public Population Project in Genomics, and the International Cancer Genome Consortium.
Population Genetics has named Alan Schafer as its new CEO. Schafer is an adjunct professor at Imperial College London Business School and was previously the Wellcome Trust's director of science funding. Before that he served as global vice president of technology development at GlaxoSmithKline and co-founded Hexagen, a functional genomics company that was acquired by Incyte.
Jeffrey Crisan and Sheli Rosenberg will not stand for re-election to Nanoshpere's board of directors and will instead retire and resign from the board when their current terms are over at the end of May. The company plans to reduce the size of its board from seven to six members after the retirements, and will nominate six nominees for election at its upcoming meeting.
New Zealand-based cancer diagnostics company Pacific Edge has appointed Jackie Walker to be CEO of its Pacific Edge Diagnostics USA subsidiary. Walker will be based at the company's new lab and US headquarters in Hershey, Penn. She recently was CEO of OSspray, a UK biotech start-up.
Trovagene has named Carlo Croce to serve on its scientific advisory board. Croce is director of the Human Cancer Genetics Program and the Genetics Institute at The Ohio State University, and he is John W. Wolfe Chair in Human Cancer Genetics.
Ariosa Diagnostics has named Thomas Musci to be VP of clinical development and medical affairs. Musci was chair of the Genetics Committee for the American Congress of Obstetricians and Gynecologists, he is a member of the Professional Practice Guidelines Committee for the American College of Medical Genetics, and retains an appointment as associate clinical professor with the Department of Obstetrics and Gynecology at the University of California, San Francisco. He also formerly was director of clinical affairs for Predictive Health and Novartis Diagnostics.
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.